Induction of stable drug resistance in human breast cancer cells using a combinatorial zinc finger transcription

Jeongeun Lee1, Andrew S Hirsh, Ben S Wittner

  • 1Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.

Plos One
|August 6, 2011
PubMed

Insights

Artificial zinc-finger transcription factors (ZF-TFs) can induce drug resistance in breast cancer cells. This study identified a common gene signature associated with fulvestrant resistance and poor prognosis.

Area of Science:

  • Cancer biology
  • Molecular oncology
  • Drug resistance mechanisms

Background:

  • Fulvestrant is a key anti-endocrine therapy for estrogen receptor-positive breast cancer.
  • Acquisition of drug resistance limits the long-term efficacy of fulvestrant treatment.
  • Understanding resistance mechanisms is crucial for developing improved therapeutic strategies.

Purpose of the Study:

  • To investigate the mechanisms of fulvestrant resistance in breast cancer using artificial zinc-finger transcription factor (ZF-TF) libraries.
  • To identify a gene expression signature associated with acquired fulvestrant resistance.
  • To explore the clinical relevance of the identified resistance signature.

Main Methods:

  • Utilized a combinatorial library of nearly 400,000 artificial ZF-TFs to induce drug resistance in breast cancer cell lines.
  • Performed comparative gene expression profiling on ZF-TF-transduced cells.
  • Conducted pathway enrichment analysis on differentially expressed genes.
  • Interrogated public human breast cancer datasets to assess the prognostic value of the resistance signature.

Main Results:

  • Isolated six ZF-TF library members that induced stable, long-term fulvestrant resistance in breast cancer cells.
  • Identified a common gene expression signature shared across all resistant cell lines.
  • This signature overlapped with estrogen receptor-negative states and resistance to other anti-endocrine agents.
  • Unique gene clusters were associated with myb-regulated genes.
  • The common resistance signature was linked to poor prognosis in independent patient datasets.

Conclusions:

  • Artificial ZF-TF libraries are effective tools for inducing and studying stable drug resistance in cancer cell lines.
  • A novel gene expression signature associated with fulvestrant resistance and poor clinical outcome was identified.
  • This signature provides insights into resistance mechanisms and potential therapeutic targets in breast cancer.